{
    "clinical_study": {
        "@rank": "94317", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Determine basal and postmethionine plasma homocysteine in patients with\n      premature vascular disease, cystathionine beta-synthase (CBS) or methylenetitrahydrofolate\n      reductase (MTHFR) deficiency, and in obligate heterozygotes for CBS or MTHFR.\n\n      II.  Determine whole-body homocysteine metabolic rates with isotopically-labeled methionine."
        }, 
        "brief_title": "Study of Homocysteine Metabolism in Homocystinuria", 
        "completion_date": "October 2000", 
        "condition": "Homocystinuria", 
        "condition_browse": {
            "mesh_term": "Homocystinuria"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a two-part study of homocysteine metabolism.  Age-matched normal\n      controls are entered in both parts of the study.\n\n      In first part of the study, participants are given oral methionine; baseline and\n      postmethionine studies include amino acid quantitation, analysis of rapidly deproteinized\n      plasma, and total plasma homocysteine.\n\n      In the second part of the study, participants (men and postmenopausal women only) undergo\n      methionine tracer studies."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n        Known or suspected homocystinuria Cystathionine beta-synthase-deficient homocystinuria\n        Obligate heterozygotes for cystathionine beta-synthase deficiency Premature vascular\n        disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "60", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004356", 
            "org_study_id": "199/11920", 
            "secondary_id": "UCSD-1033"
        }, 
        "keyword": [
            "homocystinuria", 
            "inborn errors of metabolism", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "University of California, San Diego", 
            "last_name": "Bruce Barshop", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": {
            "citation": "Page T, Barshop BA, Yu A, et al.: Treatment of Lesch-Nyhan syndrome with AICAR. In: Sahota A, Tayor M, eds.: Purine and Pyrimidine Metabolism in Man VIII. Plenum Press, New York, NY: 1995, pp 353-356."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004356"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of California, San Diego", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "February 1995", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "December 2001"
    }, 
    "geocoordinates": {}
}